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Red cell Na1/Li1 countertransport and Na1/H1 exchanger iso- nephropathy [6, 7], in whom it was related to a less
forms in human proximal tubules. favorable disease outcome [8, 9]. A genetic association
Background. Increased activity of the Na1/Li1 counter- of SLC activity with IgA nephropathy was suggestedtransporter (SLC) is a well-recognized intermediate phenotype
by the demonstration of elevated standard SLC activityof hypertension and diabetic nephropathy and may indicate a
in normotensive relatives of patients with IgA nephrop-predisposition to hypertension. Previous work has attempted
to link this membrane transport marker to altered Na1 reab- athy [8].
sorption in the proximal tubule. Since the Na1/H1 exchanger Recent evidence has also demonstrated that this SLC
(NHE) isoforms 1 and 3 are expressed in the basolateral and marker predicts future development of both hyperten-apical membranes of the proximal tubule, respectively, we in-
sion [10] and diabetic nephropathy [11, 12]. Anothervestigated the relationship between these transport proteins
and red cell SLC to examine whether the peripheral blood transporter that has been linked to both hypertension
transport phenotype is associated with altered levels of trans- and diabetic nephropathy is the Na1/H1 exchanger iso-
port proteins in the proximal tubule. form 1 (NHE-1) [13–15], where increased activity is not
Methods. Proximal tubules were prepared from human ne-
associated with increased protein expression [16, 17].phrectomy specimens. NHE-1 and NHE-3 were detected on
Although there are similarities between these two trans-Western blots by specific antibodies. Red cell SLC was also
measured. porters, recent evidence suggests that SLC may not be
Results. Both NHE-1 and NHE-3 proteins were demon- mediated by the best characterized NHE isoform,
strated, with molecular weights of 97 and 85 kD, respectively. NHE-1, the former being phloretin sensitive and theSLC was very strongly correlated with the level of NHE-3
latter amiloride sensitive [18, 19]. SLC may be thus medi-protein (r 5 0.78, P , 0.001) and was negatively related to
ated by a NHE isoform that is not NHE-1 [18].NHE-1 protein (r 5 20.32). In multiple regression analysis,
only NHE-3 and NHE-1 protein levels were significant pre- The NHEs represent a growing family of membrane
dictors of red cell SLC, accounting for up to about 70% of the transporters that use the extracellular to intracellular
variance of this parameter.
Na1 gradient to drive H1 efflux from cells [20–22].Conclusions. We conclude that red cell SLC may be a
Among the essential functions performed by this groupmarker of increased NHE-3 protein expression in the proximal
tubule, which may account for the blunted pressure natriuresis of transporters are the regulation of cell volume and pH,
and predisposition to hypertension. a permissive role in cell proliferation, and the trans-
epithelial transport of Na1 [20–22]. The cloning of the
amiloride-sensitive growth factor activatable NHE iso-
Elevated erythrocyte sodium-lithium countertransport form, called NHE-1 [23], has enabled further isoforms
(SLC) activity identifies a group of essential hypertensive to be characterized. NHE-1 is present in most types of
patients with a genetic predisposition to hypertension tissue [24] and is likely to have a “housekeeping” role
and cardiovascular disease [1–3]. Similarly, elevated SLC in regulating cell pHi and volume. NHE-1 is not the only
activity has been reported in subjects with diabetic ne- isoform present in Na1 reabsorbing epithelia such as gut
phropathy [4, 5] and in hypertensive patients with IgA and kidney (where it is localized mainly to the basolateral
membranes). In such tissues, NHE-3 and NHE-4 have
been described [24, 25] in which these isoforms are locatedKey words: sodium/hydrogen exchanger, sodium/lithium countertrans-
port, hypertension, diabetic nephropathy, natriuresis. on the apical membrane of epithelial cells. Therefore,
in the rat, it appears that kidney tissue contains mRNAReceived for publication October 22, 1999
of all four isoforms, but the abundance varies in theand in revised form January 27, 2000
Accepted for publication February 10, 2000 order NHE-3 . NHE-1 .. (NHE-2 and NHE-4) [24].
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the pressure-natriuresis mechanism in the kidney, and genase type IV, hyaluronidase type 1S, soybean trypsin
in hypertension this phenomenon is blunted [26, 27]. The inhibitor, and fluorescamine were supplied by Sigma
proximal tubule is the major site for H1 secretion, Na1 Chemical Co. (Poole, UK). Protein A Sepharose CL4B
and HCO32reabsorption, and is therefore important for was from Pharmacia LKB Biotechnology (Uppsala, Swe-
both acid-base and Na1 homeostasis [28]. It has been den). Protogel acrylamide solution was obtained from
suggested that proximal tubule Na1 reabsorption, as National Diagnostics (Atlanta, GA, USA). X-ray film
measured by Li1 clearance, is increased in both hyper- was from Genetic Research Instrumentation Ltd. (Essex,
tensive humans [29–32] and rats [33–35] and could ac- UK). Hybond C extra supported nitrocellulose, horse-
count for the blunted pressure-induced natriuresis. Re- radish peroxidase-conjugated donkey antirabbit anti-
cent research on modeling the Na1 reabsorption of body, and enhanced chemiluminescence (ECL) Western
proximal tubules has suggested that only a 14% increase blotting reagents were obtained from Amersham Inter-
in apical NHE activity may increase Na1 reabsorption national (Amersham, Little Chalfont, Buckinghamshire,
(by 8%), which is sufficient to raise blood pressure [36]. UK). Molecular weight markers, TEMED, and ammo-
In rat proximal tubules, the increased Na1 reabsorption nium persulfate were from Bio-Rad (Hercules, CA,
has been attributed to increased NHE activity [37, 38], USA).
and characterization of the NHE isoforms with isoform
specific antibodies led to documentation of increased Patients
apical membrane NHE-3 expression but no difference
Seventeen Caucasian patients (8 males) admitted toin the NHE-1 protein expression [38].
the urology ward for unilateral nephrectomy were stud-There is some in vivo evidence from humans that renal
ied. All patients had a unilateral renal tumor. PatientsLi1 clearance (representing proximal tubule Na1 han-
with diabetes or known parenchymal renal disease weredling) is reduced in patients with hypertension, especially
excluded from the study. All patients gave informedthose who had a high red cell SLC [39, 40]. These findings
consent for this study, which was approved by the Lei-were not always confirmed by other investigators, how-
cestershire Health Authority Ethics Committee.ever, perhaps because of patient selection [41, 42]. As Li1
Patients were considered to be hypertensive if theyclearance or Na1 reabsorption by the proximal tubule is
were already receiving antihypertensive medication orthe net result of a number of different transporters (api-
if their systolic blood pressure was .160 mm Hg and/orcal NHE-3 and basolateral Na1,K1-ATPase and sodium
diastolic blood pressure was .95 mm Hg during thebicarbonate cotransporter), it is not currently known
hospital admission. Nine patients were receiving one orwhether the phenotype of increased SLC reflects an al-
tered expression of these transporters. NHE-3 would be more antihypertensive medications: two b-blockers, five
the prime candidate for a transporter controlling Na1 calcium antagonists, three angiotensin-converting en-
reabsorption in the proximal tubule since it mediates zyme inhibitors, five diuretics, and one vasodilator. One
Na1 movement across the apical membrane and exhibits or more additional medications (1 thyroxine, 2 warfarin,
increased protein expression in hypertensive rat proxi- 2 isosorbide mononitrate, 2 ferrous sulfate, 1 tamoxifen,
mal tubules [38], while NHE-1 on the basolateral mem- 3 aspirin, 2 statin) were taken by five patients. Eight
brane mediates a housekeeping role. The basolateral subjects were normotensive (blood pressure of less than
Na1,K1-ATPase generates the trans-cellular Na1 gradi- 140/90 mm Hg).
ent, which operates the NHE-3–mediated apical Na1 Patients were interviewed to ascertain the presence
influx. of a family history of hypertension and cardiovascular
In the present investigation, we have therefore deter- disease in first-degree relatives. A blood sample was then
mined the levels of NHE isoform proteins in freshly taken for SLC assay.
isolated proximal tubule cells from human patients un- The patients underwent a nephrectomy, and kidney
dergoing nephrectomy. Simultaneously, the red cells cortex from the opposite pole of the kidney that was not
have been isolated and the SLC activity measured. This invaded by tumor was dissected away from the specimen.
enabled an analysis of the relationship between the phe-
The slices of cortex were kept in ice-cool Ham’s F12/notype of increased SLC and altered expression of proxi-
DMEM (1:1) medium containing 2 mmol/L glutamine,mal tubule NHE isoforms. Our findings suggest a strong
10 mmol/L pyruvate, and antibiotics until extraction ofcorrelation between red cell SLC and proximal tubule
the proximal tubules.NHE-3 expression, which could explain the increased
Na1 reabsorption in this tubule segment in vivo. Preparation of human proximal tubules
The slices of human renal cortex were washed free of
METHODS blood with ice-cold preoxygenated DMEM/Ham’s F12
Materials medium. The method for preparing proximal tubule seg-
ments was modified from Gesek, Wolff, and StrandhoyHam’s F12 medium and Dulbecco’s modified Eagle’s
medium (DMEM), fetal calf serum (FCS), Percoll, colla- [43] and had been demonstrated to be effective in purifi-
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cation of rat proximal tubules [38]. Briefly, the cortical NHE-3 protein and was raised against a fusion protein
consisting of glutathione-S-transferase and amino acidstissue was finely minced and transferred to siliconized
flasks containing an enzyme solution saturated with 95% 528 to 636 of the rat NHE-3 protein (which shows exten-
sive homology to the human sequence) [38]. After exten-O2, 5% CO2 (DMEM/Ham’s F12 with added collagenase
type IV 1 g/L, hyaluronidase type 1S 1 g/L, soybean sive washes in TBS-Tween, blots were developed with
horseradish peroxidase-linked donkey antirabbit secondtrypsin inhibitor 0.5 g/L, glutamine 2 mmol/L, pyruvate
10 mmol/L, pH 7.4, with HEPES/NaOH). The tissue was antibody (1:1500 dilution) with ECL detection according
to manufacturer’s instructions (Amersham). Bands cor-gently agitated in a 378C incubator over 90 minutes,
and digestion was usually complete by this period. The responding to NHE-1 (approximately 97 kD molecular
weight) and NHE-3 (approximately 85 kD) were quanti-supernatant containing crude tubule segments was re-
moved from the siliconized flasks at 10-minute intervals tated using a Bio-Rad densitometer and expressed as
arbitrary units. These analyses were performed with theand pelleted by brief centrifugation (60 3 g for 30 s).
Residual enzyme was washed off the pellets with oxygen- investigator blinded to the status of the patient’s SLC
values.ated ice-cold DMEM medium containing 10% FCS. At
the end of the digestion, the crude tubule fragments were
Red cell Na1/Li1 countertransport assaylayered onto a preformed 43% Percoll gradient. The
tubes were centrifuged at 1100 3 g for 20 minutes in The method used was similar to that described by
Canessa et al [1], with modifications as previously de-a cold centrifuge. The proximal tubule segments were
recovered at a density of 1.076 to 1.088 g/mL and pel- scribed [44]. Venous blood was taken into tubes con-
taining lithium-heparin and centrifuged for five minutesleted. The tubules were washed free of Percoll with ice-
cold DMEM/Ham’s F12 medium and then pelleted. at 2500 3 g. Cells (2 mL) were suspended in lithium
loading solution (8 mL; 140 mmol/L LiCl, 10 mmol/LMicroscopy at this stage showed tubules with typical
proximal tubule morphology, with granular cytoplasm glucose, 10 mmol/L lithium carbonate, 10 mmol/L Tris
acetate, pH 7.4; 5% carbon dioxide/95% oxygen wasand a brush border.
bubbled through the solution until lithium carbonate
Determination of NHE-1 and NHE-3 protein dissolved) for two hours at 378C. The erythrocytes were
abundance by Western blotting then washed twice with isotonic MgCl2 (285 mOsm/kg)
and twice with choline medium (139 mmol/L cholineThe freshly isolated proximal tubule segments were
suspended in homogenization buffer consisting of (in chloride, 1 mmol/L MgCl2, 10 mmol/L glucose, 10 mmol/L
Tris MOPS, pH 7.4, 290 mOsm/kg). The cells were resus-mmol/L) ethylenediaminetetraacetic acid (EDTA) 5,
phenylmethylsulfonyl fluoride 1, phenanthroline 1, iodo- pended and incubated in choline medium for five minutes
at 378C.acetamide 1 (in mg/mL), pepstatin 1, leupeptin 2, in phos-
phate-buffered saline. The tubule suspension was solubi- Cells (0.2 mL) were incubated in either 1.2 mL choline
medium containing 1023 mol/L ouabain (sodium free) orlized by adding Laemmli gel sample buffer [125 mmol/L
Tris, pH 6.8, 4% sodium dodecyl sulfate (SDS), 20% 1.2 mL sodium-containing medium (145 mmol/L NaCl, 1
mmol/L MgCl2, 10 mmol/L glucose, 10 mmol/L Trisglycerol, 0.004% bromophenol blue], was sonicated
briefly, and was then boiled for five minutes. Protein MOPS, pH 7.4, 290 mOsm/kg) in the presence of 1023
mol/L ouabain for 40, 80, and 120 minutes at 378C. Theconcentrations were determined with a Bio-Rad deter-
gent compatible protein assay kit and were also checked samples were sedimented at 2000 3 g for five minutes,
and 200 mL of supernatant were withdrawn. The super-by the fluorescamine protein assay [38]. The proteins
(100 mg) of extracts from each preparation were resolved natant was added to 2 mL CsCl (1.65 mmol/L) prior to
measurement of lithium content using an Instrumenta-on 7.5% SDS-polyacrylamide gel electrophoresis (SDS-
PAGE) gels followed by electrotransfer onto supported tion Laboratories IL943 flame photometer. The packed
cell volume of the initial blood sample was measurednitrocellulose. These nitrocellulose membranes were
blocked overnight with 10% low-fat milk powder (Mar- using a microhematocrit. The SLC activity was deter-
mined from the difference in lithium efflux from erythro-vel, Premier Brands UK, Ltd., Wirral, Merseyside, UK)
in 20 mmol/L Tris, pH 7.4, 137 mmol/L NaCl, and 0.1% cytes in the sodium containing and sodium-free media.
The coefficient of variation of repeated assays was 9.8%.Tween 20 (TBS-Tween).
Western blotting of these membranes was performed
Statisticsby the addition of 1 mg/mL of G252 antibody or 2 mg/mL
of G110 antibody in 5% Marvel in TBS-Tween for two Results are expressed as means 6 SEM, and ranges
are also reported. The degree of association betweenhours. The antibody G252 is specific for NHE-1 protein
and was raised against a fusion protein consisting of SLC and each of the continuous variables log NHE-3
protein, NHE-1 protein, age, creatinine, and blood pres-b-galactosidase and amino acids 650 to 815 of the human
NHE-1 sequence [16, 17]. Antibody G110 is specific for sures was quantitated using Pearson’s rank correlation
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Table 1. Clinical details, red cell and proximal tubule measurements
of the patients in the study
Mean SEM Range
Number male 17 (8)
Age years 59.7 2.1 44–72
Hypertension 9
Treatment
Beta blocker 2
Calcium antagonist 5 Fig. 1. Western blot of protein extracts from freshly isolated proximal
ACE inhibitors 3 tubule segments from patients with varying Na1/Li1 countertransport
Diuretics 5 (SLC) values (denoted above the lanes in mmol Li L21 h21). Equal
Vasodilators 1 amounts of protein (100 mg) were loaded per lane. The Na1/H1 ex-
Family history of hypertension 4 changer (NHE-1) specific antibody (G252) revealed immunoreactivity
Creatinine lmol/L 93.6 5.6 56–139 at around 97 kD. The NHE-3–specific antibody (G110) revealed the
Systolic blood pressure mm Hg 150 4.5 115–180 presence of NHE-3 protein at around 85 kD.
Diastolic blood pressure mm Hg 87 2.3 59–100
Red cell measurements
Na1/Li1 countertransport
mmol L21 h21 0.347 0.035 0.08–0.69
Proximal tubule measurements was not significant (r 5 20.32; Fig. 2). There was no
NHE-1 protein arbitrary units 1.17 0.19 0.31–2.81 correlation between NHE-1 and log NHE-3 protein con-
NHE-3 protein arbitrary units 1.86 0.37 0.53–6.73
tents of the tubule extracts (r 5 20.03). Log NHE-3
protein content was also directly correlated to the sys-
tolic blood pressure (r 5 0.50, P , 0.04) but not to the
diastolic blood pressure (r 5 20.05). There were nocoefficient. Predictive models for the response variable
significant correlations between NHE-1 content and sys-(SLC) were developed using multiple linear regression
tolic (r 5 0.12) or diastolic (r 5 0.06) blood pressures.analysis, stepwise logistic regression analysis, and best
On multiple-regression analysis in the whole popula-subsets analysis. All statistical analyses were carried out
tion using NHE-1 and NHE-3 protein contents, age, andusing the software package Minitab (Minitab Inc., Cov-
creatinine as continuous variables and family history ofentry, UK). Two-tailed P values less than 0.05 were con-
hypertension and presence of hypertension as categori-sidered significant.
cal variables in the prediction of red cell SLC, the only
variables independently associated with red cell SLC was
RESULTS log NHE-3 protein content (regression coefficient 0.434,
The demographic details of the patients in the study P , 0.001) and NHE-1 protein content (regression coef-
are reported in Table 1. The SLC of the red cells ranged ficient 20.068, P , 0.03). Likewise, in a stepwise logistic
from 0.08 to 0.69 mmol/L/h, with a mean of 0.35 mmol/ model, the only variables entered for prediction of SLC
L/h. All of the proximal tubule extracts from the kidney were (1) log NHE-3 protein content (r 2 5 59.8%) and
biopsies expressed both NHE-3 and NHE-1 protein, and (2) NHE-1 protein content (r 2 5 71.9%). Using a best
an example of a Western blot for these proteins is shown subset analysis, log NHE-3 protein alone (r 2 5 57.1%)
in Figure 1. NHE-3 protein was detected as an 85 kD was a better predictor of SLC than any other single
protein. NHE-1 protein ranged in molecular weight from variable. The predictive value of the model was improved
92 to 110 kD, with a mean of 97 kD. These molecular slightly by consideration of combinations of variables,
weights of human proximal tubule NHE-1 and NHE-3 all of which included log NHE-3 protein content: log
proteins are similar to those reported previously in rat NHE-3 protein content 1 NHE-1 protein content (r 2 5
proximal tubules [38]. The densities of these NHE-1 and 67.9%); log NHE-3 protein content 1 family history of
NHE-3 protein bands were scanned, and arbitrary units hypertension (r 2 5 61.6%); log NHE-3 protein content 1
are reported (Table 1). The only variable that did not NHE-1 protein content 1 family history of hypertension
exhibit a Gaussian distribution was NHE-3 protein con- (r 2 5 71.9%). Thus, in all models, proximal tubule
tent, and this was therefore normalized by log transfor- NHE-3 protein content accounted for a very substantial
mation before further analysis. proportion of the total variance in red cell SLC.
In Figure 1, proximal tubule extracts from patients
with high and low red cell SLC values had similarly high
DISCUSSIONand low NHE-3 protein densities. On regression analysis
Although SLC has long been recognized as a markerof the whole population, a very significant correlation
for predisposition for hypertension [1, 10] and other re-was documented between log NHE-3 protein content of
nal diseases such as diabetic nephropathy [2, 3, 11, 12],the proximal tubule extracts and the SLC in the red cells
the actual transport mechanism that it represents in red(r 5 0.78, P , 0.001; Fig. 2). In contrast, although NHE-1
protein content was inversely correlated to SLC, this cells has never been elucidated. However, it has been
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creased activity in proximal tubules [37, 38], there was no
evidence for increased NHE-1 protein expression [38].
Thus, the findings in the present study of a slight negative
but insignificant correlation between SLC and NHE-1
protein is not surprising. However, when a NHE isoform
is overexpressed on the brush border of kidney tubules,
such as in the NHE-1 transgenic mouse, salt-sensitive
hypertension results from the increased renal Na1 reab-
sorption [48]. Similarly, in the hypertensive rat, there
is evidence for overexpression of NHE-3 at the apical
membrane of the proximal tubule [38]. Our present find-
ings of increased NHE-3 protein in human proximal tu-
bule extracts from those patients with high SLC concur
with these findings in the hypertensive rat and reinforce
the red cell SLC as a phenotypic marker for increased
proximal tubule Na1 reabsorption through the apical
membrane NHE-3 protein. The reason for this associa-Fig. 2. Scatterplot illustrating the relationship between red cell SLC
values and the density of NHE-1 (m) or NHE-3 (s) protein (in arbitrary tion is not apparent at the moment. Although NHE-3
units). Pearson’s correlation coefficients between SLC and NHE-3 pro- shares the property of amiloride insensitivity with SLC,
tein were very significant (r 5 0.78, P , 0.001).
there are no data on its sensitivity to phloretin. In addi-
tion, NHE-3 activity is inhibited by cell shrinkage, but
SLC is unaffected. Furthermore, the absence of NHE-3
protein in red cells [45] makes it unlikely that this proteinpostulated that it may represent a mode of operation of
the NHE-1. This has, however, been refuted by pharma- mediates SLC, and may imply that similar cellular regula-
tory control mechanisms (for example, accessory pro-cological studies on SLC and NHE activity in red cells
[18, 19]. For example, SLC is phloretin sensitive and teins) exist for the proximal tubule NHE-3 and the novel
NHE isoform [18] that could mediate SLC. There isamiloride insensitive, whereas NHE-1 fluxes are phlo-
retin insensitive and amiloride sensitive. In addition, evidence of a role for accessory proteins (called NHE
regulatory factor, or NHE-RF) in the control of NHE-3NHE-1 is activated by osmotic shrinking, but SLC is not
affected. Although there is evidence for the presence of activity [49, 50], especially in the effect of protein kinase
A-mediated inhibition of NHE-3 activity. The possibilityNHE-1 in red cells, amiloride-insensitive isoforms such
as NHE-3 protein are absent [45]. This led to proposals that variance in SLC could be mediated by differences
in NHE-RF expression in both red cells and tubule cellsthat a novel NHE isoform was involved [18].
Others have postulated that SLC may be related to remains to be examined. Nevertheless, our present find-
ings of increased NHE-3 protein expression could ex-the reabsorption of Na1 in the proximal tubule, this
parameter being determined indirectly by Li1 clearance plain the reports of reduced renal Li1 clearance in those
patients with high red cell SLC previously documented[39, 40]. Weder reported an inverse relationship between
SLC and Li1 clearance, implying that there was increased by others [39, 40]. Furthermore, the addition of family
history of hypertension and NHE-1 protein levels to theproximal tubule Na1 reabsorption [39]. However, this
finding was not confirmed by other groups [41, 42]. This NHE-3 protein levels improved the prediction of red
cell SLC.may not be surprising since the reabsorption of Na1 in
the proximal tubule is complex and depends on a number Our present findings that NHE-3 is a homogeneous
85 kD protein concur with other reports of the size ofof different transport mechanisms.
Recent evidence indicates the absorption of Na1 and this protein in rat tissue [46, 47, 51] in which the size has
been estimated to range between 80 and 87 kD, and inHCO32 by the proximal tubules is mediated to a large
extent by operation of NHEs [28]. The apical localization rat proximal tubules in which the size was estimated
at 85 kD [38]. NHE-3 is not N-glycosylated, hence itsof NHE-3 [46, 47] in particular is suggestive of a primary
role in Na1 absorption, with the basolateral Na1,K1- homogeneous molecular mass. In contrast, the molecular
weight heterogeneity of human proximal tubule NHE-1ATPase responsible for creating the trans-apical mem-
brane Na1 gradient. NHE-1 is localized on the baso-lat- immunoreactivity may be due to N-linked glycosylation
[16, 17, 21, 22].eral membrane [38] and has been suggested to perform
an intracellular pH “housekeeping” regulatory role A limitation of our study is the relatively small number
of patients caused by the relative paucity of suitablerather than one directly involved with Na1 absorption.
In hypertension, although there is evidence that NHE-1, cases. In addition, the presence of the renal tumor may
have influenced both red cell and proximal tubule trans-the isoform that is most frequently studied, exhibits in-
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Crepaldi G, Nosadini R: Elevated sodium-lithium countertrans-porters, but it is likely that they would have been affected
port activity in erythrocytes is predictive of the development of
in a similar fashion. In addition, functional transport microalbuminuria in IDDM. Diabetologia 40:654–661, 1997
13. Rosskopf D, Dusing R, Siffert W: Membrane sodium-protonstudies were not possible, as the enzymatic digestion of
exchange and primary hypertension. Hypertension 21:607–617,renal slices could have affected the membrane perme-
1993
ability of the tubule cells. 14. Ng LL, Fennell DA, Dudley C: Kinetics of the human leukocyte
Na1-H1 antiport in essential hypertension. J Hypertens 8:533–537,In summary, to our knowledge this is the first report
1990of NHE isoforms in the proximal tubule of humans. A
15. Ng LL, Simmons D, Frighi V, Garrido MC, Bomford J, Hockaday
strong correlation between red cell SLC and proximal TDR: Leukocyte Na1/H1 antiport activity in type 1 insulin depen-
dent diabetic patients with nephropathy. Diabetologia 33:371–377,tubule NHE-3 protein expression was documented,
1990which could explain previous findings of an association
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betic patients with nephropathy. J Clin Invest 93:2750–2757, 1994environmental factors such as salt intake, these findings
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may explain the robustness of SLC as a predictive marker lewski B, Krolewski AS: Na1/H1 antiporter phenotype, abun-
dance and phosphorylation of immortalized lymphoblasts fromfor future blood pressure and diabetic renal disease.
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